Le Lézard
Classified in: Health
Subjects: CCA, FVT

SmartPharm Therapeutics Announces Presentation at the 2019 BIO Investor Forum


CAMBRIDGE, Mass., Oct. 16, 2019 /PRNewswire/ -- SmartPharm Therapeutics, a preclinical-stage pharmaceutical company focused on developing next-generation, non-viral gene therapies for the treatment of rare diseases, today announced that José Trevejo, MD, PhD, Chief Executive Officer, will present at the 2019 BIO Investor Forum on Wednesday, October 23 at 9:00 a.m. PT in San Francisco.

A live audio webcast and replay of the presentation will be available on the "News & Events" section of the Company's website at https://smartpharmtx.com/news.

About SmartPharm Therapeutics

SmartPharm Therapeutics Inc. is a privately held, development-stage pharmaceutical company focused on developing next-generation, non-viral gene therapies for the treatment of serious- and rare diseases with the vision of creating "Biologics from Within." The Company is currently developing a novel pipeline of non-viral, gene-encoded proteins for the treatment of conditions that require enzyme replacement therapy and tissue restoration. SmartPharm commenced operations in 2018 and is headquartered in Cambridge, MA, USA. For more information, please visit www.smartpharmtx.com.

Contacts




Investors

Media

Ryan Baker

David Rosen

Argot Partners

Argot Partners

212.600.1902 | [email protected]

212.600.1902 | [email protected]

SOURCE SmartPharm Therapeutics


These press releases may also interest you

at 11:34
Report from Annual General Meeting of Vitrolife AB (publ)
At the Annual General Meeting of Vitrolife AB today, the following, amongst other things, was decided: Resolution in accordance with the Board's proposed dividend of SEK 1.00 per share for the financial year 2023. 29 April, 2024 was adopted as the...

at 11:25
TimelyCare Earns Recognition as One of the World's Best Digital Health Companies, Earns Five Top Workplace Awards
TimelyCare, higher education's most trusted virtual health and well-being provider, has earned recognition as one of the World's Best Digital Health Companies by Newsweek, and has been awarded five Top Workplaces Awards for culture excellence....

at 11:16
Avanos Medical, Inc. to Webcast Conference Call Discussing First Quarter 2024 Financial Results
Avanos Medical, Inc. will webcast its conference call discussing financial results and business highlights for the first quarter 2024 on Thursday, May 2 at 9 a.m., ET. The company will issue a news release detailing its results before the market...

at 11:15
Avistone Announces the Approval of Vebreltinib as the First MET-TKI Treatment for a Rare Brain Glioma Subtype in China
Beijing Avistone Biotechnology Co., Ltd. (also referred to as Avistone Biotechnology or Avistone), an innovative biotechnology company focused on precision oncology therapeutics, announced the approval to expand the use of vebreltinib (also referred...

at 11:10
NJII Names New Chief Operating Officer and Executive Vice President of Healthcare Division
Through its 2030 Strategic Plan, NJII plans to double the size of the organization and to exceed $70M revenue as it rolls out various new initiatives focused on accelerating technology translation, spurring innovation and upskilling workers. As...

at 11:09
ScreenPoint Medical Leadership Transition: Pieter Kroese Confirmed as CEO
ScreenPoint Medical, today announced a significant transition in its leadership as Mark Koeniguer, the current CEO, steps down from his position. Mark served as CEO since 2022 and was instrumental in ScreenPoint's commercial growth and success over...

More news about Health...


News published on and distributed by: